0001753420-23-000001.txt : 20231003 0001753420-23-000001.hdr.sgml : 20231003 20231003151541 ACCESSION NUMBER: 0001753420-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231003 DATE AS OF CHANGE: 20231003 EFFECTIVENESS DATE: 20231003 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENB Therapeutics, Inc. CENTRAL INDEX KEY: 0001753420 IRS NUMBER: 473954174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-493707 FILM NUMBER: 231302998 BUSINESS ADDRESS: STREET 1: C/O ALEXANDRIA CENTER FOR LIFE SCIENCES STREET 2: LAUNCHLABS 430 E 29TH ST. 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 100116 BUSINESS PHONE: 212 792-2317 MAIL ADDRESS: STREET 1: C/O ALEXANDRIA CENTER FOR LIFE SCIENCES STREET 2: LAUNCHLABS 430 E 29TH ST. 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 100116 D 1 primary_doc.xml X0708 D LIVE 0001753420 ENB Therapeutics, Inc. C/O LAUNCHLABS 430 E 29th St., 14TH Floor NEW YORK NY NEW YORK 10016 212 792-2317 DELAWARE None None Corporation true 2018 Sumayah Jamal c/o LaunchLabs 430 E 29th St., 14TH Floor New York NY NEW YORK 10016 Executive Officer Director Walter Olesiak c/o LaunchLabs 430 E 29th St., 14TH Floor New York NY NEW YORK 10016 Director Stuart Hwang c/o LaunchLabs 430 E 29th St., 14TH Floor New York NY NEW YORK 10016 Director Barbara Schilberg c/o LaunchLabs 430 E 29th St., 14TH Floor New York NY NEW YORK 10016 Director Albert Sokol c/o LaunchLabs 430 E 29th St., 14TH Floor New York NY NEW YORK 10016 Executive Officer Biotechnology Decline to Disclose 06b false 2023-09-22 false true true false 0 1000000 225000 775000 false 3 0 0 0 false ENB Therapeutics, Inc. /s/ Albert Sokol Albert Sokol Secretary 2023-10-03